About this trial
Main study objective: compare long-term buprenorphine treatment outcomes for patients who start buprenorphine for opioid use disorder (OUD) in the emergency department and are then referred to get outpatient buprenorphine treatment either via telehealth or at an in-person clinic.
Researchers will:
Compare rates of establishing outpatient OUD treatment, how long patients stay on buprenorphine, and patients' experience with care to determine whether patient experiences and outcomes are better for patients referred to telehealth treatment versus patients patients referred to in-person treatment after they leave the emergency department.
Participants will:
Be recruited from 3 different hospital emergency departments.
Answer questionnaires at baseline and then 1, 3, 6, and 9 months after their initial emergency department visit.
Eligibility criteria
Qualifiers
Adult patients who present to the emergency department and receive buprenorphine (either administered or prescribed) to treat OUD
do not have an established outpatient clinic where they will get buprenorphine when they leave the emergency department
Disqualifiers
inability to give consent
patients living in institutions (e.g., nursing homes, prisons)
unable to complete questionnaires in either English or Spanish
Trial design
Treatments tested in this trial
- referral to telehealth treatment
- referral to in person treatment
Treatment groups
Locations
3Sponsors and collaborators
University of California, Davis
Lead sponsor
Patient-Centered Outcomes Research Institute
Collaborator